The shareholders of OSM AG (“OSM”), have reached an agreement with Dedalus Italia S.p.A. (“Dedalus”), to sell 100% of the shares in OSM to Dedalus.
OSM AG is a leading laboratory information systems provider with more than 25 years of experience in the German market. The company has managed to build up a strong and diversified customer base and is the strategic partner of choice for its healthcare stakeholders. OSM’s entrepreneurial management team has been working together since its foundation and earned an outstanding success story with a remarkable market position.
Founded in Florence in 1982 by the current Chairman Giorgio Moretti, Dedalus is a leading healthcare and diagnostic software provider in Europe and owned by the private equity firm Ardian. Since 2016, Dedalus has accelerated its expansion strategy by targeting the growing demand for innovative and comprehensive ICT and Clinical transformation solutions. With the acquisition of Agfa Healthcare IT, Dedalus consolidated its leadership as pan-European player in the healthcare software industry, with a leading position in Hospital IT (HCIS) and Diagnostic (DIS) in Germany, Italy and France. In April 2021 Dedalus completed the acquisition of DXC’s healthcare IT business, continuing its growth journey. Today Dedalus has a strong footprint in UK and Ireland, Northern Europe, Austria, Switzerland, Spain, China, Brazil, Australia, New Zealand and several locations in Latin America, the Middle East and Africa, having a presence in over 40 different countries. Thanks to its undisputed cutting-edge portfolio of leading, new generation solutions, Dedalus covers the whole spectrum of needs for healthcare operators, supporting over 6,000 hospitals and 5,000 laboratories around the world.
Johannes Kuhn, CEO of OSM, commented, “We are very excited about the future. With our new partner Dedalus, we have secured the further growth of our laboratory management systems business.” Christian Damsky, OSM board member, adds, “Becoming part of one of the world’s largest healthcare IT companies will open up new markets for us and ensure that we can continue to offer ‘state-of-the-art’ solutions to our existing and new customers.”
Andrea Fiumicelli, CEO of Dedalus Group, stated: “A key part of Dedalus’ success story has been the consolidation of diagnostic IT solutions, first in Italy and, since 2016, in the French market. Through our acquisition of OSM, we are further strengthening our leadership position in the European Laboratory Information System marketplace, a critical diagnostic sector to fast track the healthcare ecosystem digital transformation and the enablement of the continuum of care. In addition, this acquisition also clearly underlines the importance of DACH to Dedalus’ growth strategy.”
CASE Corporate Finance Germany acted as sole financial adviser to the shareholders of OSM.